[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 20, Issue 3 (7-2022) ::
Int J Radiat Res 2022, 20(3): 601-605 Back to browse issues page
Clinical outcomes of adjuvant radiotherapy for nodal negative T1 and T2 breast cancer
I.A. Cetin , S.U. Akay , H.B.C. Ozkok , M. Sengoz
Marmara University, Faculty of Medicine Department of Radiation Oncology Fevzi Cakmak Mah, Istanbul, Turkey , ilknurcet@gmail.com
Abstract:   (770 Views)
Background: The objective of this study was to determine the long-term results of postoperative radiotherapy (RT) in patients with node-negative T1–T2 breast cancer and the prognostic factors affecting these results. Materials and Methods: We retrospectively evaluated 382 node-negative breast cancer patients (pT1a–c, T2) treated with surgery. All patients underwent postoperative RT and 80% of patients received hormone therapy. Prognostic variables included patient characteristics, disease characteristics, and intervention factors. The primary endpoint was overall survival (OS). Survival curves were estimated using the Kaplan–Meier method. Differences in observed survival distributions among patient subgroups were evaluated using a two-sided long-rank test. We applied univariate and multivariate Cox models to evaluate predictive factors. Statistical significance was evaluated at a level of P < 0.05. Results: The median follow-up was 143 months. The 10-, 15-, and 20-year OS rates were 92%, 86%, and 80%, respectively. Univariate analysis showed that age (< 45, 45–65, > 65 years; P < 0.0001), comorbidity (P = 0.008), menopausal status (P = 0.03), and tumor stage (T1a–c, T2; P = 0.006) (table 1) were significant predictors of OS. Multivariate analysis showed that age (< 45, 45–65, > 65; P = 0.01) and tumor stage (T1a–c, T2; P < 0.0001) were independent predictors of OS. At age 15 years, the OS rate of patients with T1b, T1c, or T2 stage cancer was 87.5%, 81%, or 77%, respectively. Conclusions: Age and tumor stage were independent prognostic factors for women with node-negative early breast cancer.
Keywords: Early-stage breast cancer, prognostic factors, radiotherapy, survival.
Full-Text [PDF 1474 kb]   (325 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
References
1. Siegel RL, Miller KD, Jemal A. Cancer statistics (2016) Cancer statistics. CA Cancer J Clin, 66(1): 7e30. [DOI:10.3322/caac.21332] [PMID]
2. Clark RM, McCullogh PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. (1992) Randomized clinical trial to assess the effectiveness of breast irriditation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst, 84: 683-689. [DOI:10.1093/jnci/84.9.683] [PMID]
3. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. (1993) Radiotherapy after breast-preserving surgery in women with localised cancer of the breast. New Engl J Med, 328(22): 1587-1591. [DOI:10.1056/NEJM199306033282202] [PMID]
4. Liljegren G, Holmberg L and Adami HO (1994) Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst, 86: 717-722. [DOI:10.1093/jnci/86.9.717] [PMID]
5. Fisher B, Andersson S, Redmond CK, Wolmark N, Wickerham DL and Cronin WM (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med, 333: 1456-1461. [DOI:10.1056/NEJM199511303332203] [PMID]
6. Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, et al. (1995) Breast conservation is a safe method in patients with small cancer of the breast: Long-term results of three randomized trials on 1,973 patients. Eur J Cancer, 31A (10): 1574-1579. [DOI:10.1016/0959-8049(95)00271-J]
7. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN (1996) Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet, 348: 708-713. https://doi.org/10.1016/S0140-6736(96)02133-2 [DOI:10.1016/S0140-6736(04)70112-9] [PMID]
8. Early Breast Cancer Trialists Collaborative Group (1995) Effects of radiotherapy and surgery in early breast cancer. N Engl J Med, 333: 1444-1455. [DOI:10.1056/NEJM199511303332202] [PMID]
9. Kurtz JM, Almaric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, et al. (1989) Local recurrence after breast-conserving surgery and radiotherapy. Cancer, 63: 1912-1917. https://doi.org/10.1002/1097-0142(19890515)63:10<1912::AID-CNCR2820631007>3.0.CO;2-Y [DOI:10.1002/1097-0142(19890515)63:103.0.CO;2-Y] [PMID]
10. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. (1992) Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer, 28A (4/5): 801-805. [DOI:10.1016/0959-8049(92)90118-L]
11. Renton SC, Gazet JC, Ford HT, Corbishley C and Sutcliffe R (1996) The importance of resection margin in conservative surgery for breast cancer. Eur J Surg Oncol, 22: 17-22. [DOI:10.1016/S0748-7983(96)91253-6] [PMID]
12. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. (1999) 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol, 17: 2326-2333. [DOI:10.1200/JCO.1999.17.8.2326] [PMID]
13. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol, 16: 441-452. [DOI:10.1200/JCO.1998.16.2.441] [PMID]
14. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347(16): 1233-41. [DOI:10.1056/NEJMoa022152] [PMID]
15. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med, 347(16):1227-32. [DOI:10.1056/NEJMoa020989] [PMID]
16. Abi-Raad R, Boutrus R, Wang R, Niemierko A, Macdonald S, Smith B, et al. (2011) Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys, 81(3): e151-7. [DOI:10.1016/j.ijrobp.2011.01.015] [PMID] []
17. Truong PT, Lesperance M, Culhaci A, Kader HA, Speers CH, Olivotto IA (2005) Patient subsets with T1- T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys, 62(1): 175-82. [DOI:10.1016/j.ijrobp.2004.09.013] [PMID]
18. Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. (2015) for the MA.20 Study Investigators. Regional nodal irradiation in early-stage breast cancer. New England Journal of Medicine, 373(4): 307-16. [DOI:10.1056/NEJMoa1415340] [PMID] []
19. Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. (2015) EORTC Radiation Oncology and Breast Cancer Groups. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med, 373(4): 317-27. [DOI:10.1056/NEJMoa1415369] [PMID]
20. Leitner SP, Swern AS, Weinberger D, Duncan LJ, Hutter RV (1995) Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0). Cancer, 76: 2266-2274. https://doi.org/10.1002/1097-0142(19951201)76:11<2266::AID-CNCR2820761114>3.0.CO;2-T [DOI:10.1002/1097-0142(19951201)76:113.0.CO;2-T] [PMID]
21. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, et al. (2007) Overall survival and cause specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J Clin Oncol, 25: 4952-4960. [DOI:10.1200/JCO.2006.08.0499] [PMID]
22. Fisher B, Dignam J, Tan-Chiu E, Anderson S, Fisher ER, Wittliff JL, et al. (2001) Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst, 93: 112-120. https://doi.org/10.1093/jnci/93.18.1421 [DOI:10.1093/jnci/93.2.112] [PMID]
23. Kennedy T, Stewart AK, Bilimoria KY, Patel-Parekh L, Sener SF, Winchester DP (2007) Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients. Ann Surg Oncol, 14: 2918-2927. [DOI:10.1245/s10434-007-9441-5] [PMID]
24. Lee AK, Loda M, Mackarem G, Bosari S, DeLellis RA, Heatley GJ, et al. (1997) Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a, bN0M0): clinicopathologic features and outcome. Cancer, 79: 761-771. https://doi.org/10.1002/(SICI)1097-0142(19970215)79:4<761::AID-CNCR13>3.0.CO;2-Y [DOI:10.1002/(SICI)1097-0142(19970215)79:43.0.CO;2-Y]
25. Trignani M, DI Carlo C, Cefalogli C, Nuzzo M, Ursini LA, Caravatta L, et al. (2017) Outcomes in Patients with pT1-T2, pN0-N1 Breast cancer After Conservative Surgery and Whole-breast Radiotherapy. In-vivo, 31(1): 151-158. [DOI:10.21873/invivo.11039] [PMID] []
26. Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, et al. (2013) Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Breast J, 19: 22-30. [DOI:10.1111/tbj.12059] [PMID]
27. Mamtani A, Patil S, Stempel M, Morrow M (2017) Are There Patients with T1-T2, Node-Negative Breast Cancer Who Are "High-Risk" for Locoregional Recurrence? Cancer, 123(14): 2626-2633. [DOI:10.1002/cncr.30658] [PMID] []
28. Truong PT, Bernstein V, Lesperance M, Speers CH, Olivotto IA (2006) Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg, 191: 749-755. [DOI:10.1016/j.amjsurg.2005.07.028] [PMID]
29. Fyles AW, McCready DR, Manchul LA, et al. (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med, 351: 963-970. [DOI:10.1056/NEJMoa040595] [PMID]
30. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, et al. (2004) Cancer and Leukemia Group B; Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med, 351: 971-977. [DOI:10.1056/NEJMoa040587] [PMID]
31. VanderWalde A and Hurria A (2012) Early breast cancer in the older woman. Clin Geriatr Med, 28(1): 1-20. [DOI:10.1016/j.cger.2011.10.002] [PMID] []
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Cetin I, Akay S, Ozkok H, Sengoz M. Clinical outcomes of adjuvant radiotherapy for nodal negative T1 and T2 breast cancer. Int J Radiat Res 2022; 20 (3) :601-605
URL: http://ijrr.com/article-1-4346-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 3 (7-2022) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 50 queries by YEKTAWEB 4645